Published in
Taylor and Francis Group, Expert Opinion on Biological Therapy, 12(22), p. 1585-1592, 2022
DOI: 10.1080/14712598.2022.2090835
Links
Tools
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year
Journal article published in 2022 by
Marco Galluzzo 
,
Marina Talamonti ,
Nicoletta Bernardini ,
Andrea Chiricozzi ,
Clara De Simone,
Claudio Bonifati ,
Pierluigi Bruni,
Federico Diotallevi ,
Maria Esposito,
Dario Graceffa,
Gaia Moretta ,
Cristina Mugheddu,
Katharina Hansel ,
Manuela Papini ,
Francesco Loconsole
and other authors.
,
Marina Talamonti ,
Nicoletta Bernardini ,
Andrea Chiricozzi ,
Clara De Simone,
Claudio Bonifati ,
Pierluigi Bruni,
Federico Diotallevi ,
Maria Esposito,
Dario Graceffa,
Gaia Moretta ,
Cristina Mugheddu,
Katharina Hansel ,
Manuela Papini ,
Francesco Loconsole
and other authors.
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 